NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NICHD E-174-2015-0-PCT-02 Diagnostic And Therapeutic Targets For Preeclampsia And Closely Related Complications Of Pregnancy PCT PCT PCT/ib/2015/05190 Expired
NCI E-230-2012-0-KR-09 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 KR National Stage 10-2015-7006543 Issued
NCI E-230-2012-0-JP-08 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 JP National Stage 2015-532065 Issued
NCI E-055-2011-0-US-04 Brachyury Protein, Non-Poxvirus Non-Yeast Vectors Encoding Brachyury Protein, and Their Use US National Stage 14/428,308 Abandoned
NCI E-230-2012-0-US-11 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 US National Stage 14/427,671 9879065 Issued PDF
NIAID E-103-2014-3-US-07 Antibody Evolution Immunogens US National Stage 14/427,581 10004800 Issued PDF
NEI E-050-2015-0-US-01 RP2 and RPGR Vectors For Treating X-linked Retinitis Pigmentosa US 62/131,661 Abandoned
NCATS E-120-2010-0-US-09 Activators Of Human Pyruvate Kinase US CON 14/643,107 9708267 Issued PDF
NIAID E-064-2015-0-US-01 MYELIN OLIGODENDROCYTE GLYCOPROTEIN, MYELIN BASIC PROTEIN, AND PROTEOLIPID PROTEIN COMPOSITIONS AND METHODS OF USE US 62/130,285 Abandoned
NCI E-223-2012-0-US-03 Co-Transcriptional Assembly of Modified RNA Nanoparticles US National Stage 14/426,707 9719084 Issued PDF
NCI E-111-2014-0-PCT-02 Methods And Compositions For Increasing A T-cell Effector Cell To Regulatory T Cell Ratio PCT PCT PCT/US2015/018915 Expired
NCI E-111-2014-0-US-15 Methods And Compositions For Increasing A T-cell Effector Cell To Regulatory T Cell Ratio US National Stage 15/123,468 Abandoned
NCI E-111-2014-0-EP-07 Methods And Compositions For Increasing A T-cell Effector Cell To Regulatory T Cell Ratio EP National Stage 15758226.3 Abandoned
NCI E-111-2014-0-JP-09 Methods And Compositions For Increasing A T-cell Effector Cell To Regulatory T Cell Ratio JP National Stage 2016-573685 Pending
NCI E-111-2014-0-MX-11 Methods And Compositions For Increasing A T-cell Effector Cell To Regulatory T Cell Ratio MX National Stage MX/a/2016/011537 Pending
NCI E-111-2014-0-RU-13 Methods And Compositions For Increasing A T-cell Effector Cell To Regulatory T Cell Ratio RU National Stage 2016138601 Abandoned
NCI E-111-2014-0-SG-14 Methods And Compositions For Increasing A T-cell Effector Cell To Regulatory T Cell Ratio SG National Stage 11201607213Q Pending
NCI E-111-2014-0-KR-10 Methods And Compositions For Increasing A T-cell Effector Cell To Regulatory T Cell Ratio KR National Stage 10-2016-7025525 Abandoned
NCI E-111-2014-0-BR-04 Methods And Compositions For Increasing A T-cell Effector Cell To Regulatory T Cell Ratio BR National Stage BR1120160203640 Abandoned
NCI E-111-2014-0-AU-03 Methods And Compositions For Increasing A T-cell Effector Cell To Regulatory T Cell Ratio AU National Stage 2015227163 Abandoned
NCI E-111-2014-0-HK-16 Methods And Compositions For Increasing A T-cell Effector Cell To Regulatory T Cell Ratio HK EP 171061130.0 Pending
NCI E-111-2014-0-IL-08 Methods And Compositions For Increasing A T-cell Effector Cell To Regulatory T Cell Ratio IL National Stage 247458 Abandoned
NCI E-111-2014-0-CN-06 Methods And Compositions For Increasing A T-cell Effector Cell To Regulatory T Cell Ratio CN National Stage 201580011943.7 Abandoned
NCI E-111-2014-0-CA-05 Methods And Compositions For Increasing A T-cell Effector Cell To Regulatory T Cell Ratio CA National Stage 2941405 Abandoned
NIAID E-220-2016-0-US-01 Serum Antibody Assay For Determining Protection From Malaria, And Pre-Erythrocytic Subunit Vaccines US 62/128,400 Abandoned
NCI E-236-2012-0-ES-11 MESOTHELIN ANTIBODIES AND METHODS FOR ELICITING POTENT ANTITUMOR ACTIVITY ES EP 13766859.6 Issued
NCI E-236-2012-0-FR-12 MESOTHELIN ANTIBODIES AND METHODS FOR ELICITING POTENT ANTITUMOR ACTIVITY FR EP 13766859.6 Issued
NCI E-236-2012-0-DE-10 MESOTHELIN ANTIBODIES AND METHODS FOR ELICITING POTENT ANTITUMOR ACTIVITY DE EP 13766859.6 Issued
NCI E-236-2012-0-GB-13 MESOTHELIN ANTIBODIES AND METHODS FOR ELICITING POTENT ANTITUMOR ACTIVITY GB EP 13766859.6 Issued
NCI E-236-2012-0-IT-14 MESOTHELIN ANTIBODIES AND METHODS FOR ELICITING POTENT ANTITUMOR ACTIVITY IT EP 13766859.6 Issued
NCI E-257-2009-1-JP-11 Use Of IL-15 To Increase Thymic Output and to Treat Lymphopenia JP DIV 2015-041346 Issued
NCI E-098-2015-0-US-01 Display Platform From Bacterial Spore Coat Proteins US 62/127,738 Abandoned
NICHD E-120-2015-0-US-12 Method For On-demand Contraception US CON 14/635,107 9283233 Issued PDF
NCI E-281-2016-0-US-01 Quinolinones and Related Compounds as Inhibitors of Translation Initiation Complex US 62/126,715 Abandoned
NIAID E-147-2015-0-CN-03 BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION CN National Stage 201580021493.X Issued
NIAID E-147-2015-0-ZA-07 BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION ZA National Stage 2016/05768 Issued
NIAID E-147-2015-0-BE-08 BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION BE EP 15708889.9 Issued
NIAID E-147-2015-0-EP-04 BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION EP National Stage 15708889.9 Issued
NIAID E-147-2015-0-CH-09 BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION CH EP 15708889.9 Issued
NIAID E-147-2015-0-GB-12 BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION GB EP 15708889.9 Issued
NIAID E-147-2015-0-DE-10 BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION DE EP 15708889.9 Issued
NIAID E-147-2015-0-FR-11 BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION FR EP 15708889.9 Issued
NIAID E-147-2015-0-PCT-02 BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION PCT PCT PCT/IB2015/051465 Expired
NIAID E-147-2015-0-IN-05 BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION IN National Stage 201617028701 Pending
NIDCR E-139-2011-1-US-06 AAV MEDIATED AQUAPORIN-1 GENE TRANSFER TO TREAT SJOGRENS SYNDROME US National Stage 14/423,774 10166299 Issued PDF
NHGRI E-092-2014-1-US-01 Sialylation-increasing Therapies For Diseases Associated With Oxidative Stress US 62/120,742 Abandoned
NIAID E-239-2014-0-US-01 MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS IMMUNOGENS, ANTIBODIES, AND THEIR USE US 62/120,353 Abandoned
NIAID E-246-2012-0-US-05 Engineered Anthrax Lethal Toxin for Targeted Delivery US National Stage 14/423,408 9730993 Issued PDF
NIDDK E-185-2012-0-US-04 Imaging and Diagnostic Methods, Systems, and Computer-Readable Media US National Stage 14/423,037 11464413 Issued PDF
NCI E-048-2012-0-US-05 Expression Protein-Coding And Noncoding Genes As Prognostic Classifiers In Early Stage Lung Cancer US National Stage 14/423,069 10047401 Issued PDF